ID   FU-SFT8710
AC   CVCL_ZE77
DR   Wikidata; Q98126279
RX   PubMed=17088980;
RX   PubMed=32642732;
CC   Population: Japanese.
CC   Doubling time: ~68 hours (PubMed=17088980).
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=17088980; DOI=10.3892/ijo.29.6.1421;
RA   Aoki M., Nabeshima K., Nishio J., Ishiguro M., Fujita C., Koga K.,
RA   Hamasaki M., Kaneko Y., Iwasaki H.;
RT   "Establishment of three malignant peripheral nerve sheath tumor cell
RT   lines, FU-SFT8611, 8710 and 9817: conventional and molecular
RT   cytogenetic characterization.";
RL   Int. J. Oncol. 29:1421-1428(2006).
//
RX   PubMed=32642732; DOI=10.1093/noajnl/vdz049; PMCID=PMC7317054;
RA   Pemov A., Li H., Presley W., Wallace M.R., Miller D.T.;
RT   "Genetics of human malignant peripheral nerve sheath tumors.";
RL   Neurooncol. Adv. 2:i50-i61(2020).
//